PDCD1 and cancer: To investigate whether the expression levels of TMPRSS2 may influence the efficacy of anti-PD1 mAb treatments, the immune cell migration, cancer cell proliferation and apoptosis were determined over three days of co-cultures between TMPRSS2low or TMPRSS2high MCF-7 and immune cells in the presence and absence of nivolumab.